Dublin, March 07, 2017 -- Research and Markets has announced the addition of the "IVD in the Middle East (Egypt, Turkey, Saudi Arabia, United Arab Emirates, Israel, Jordan, Other Mideast)" report to their offering.
In vitro diagnostic (IVD) companies are casting their nets in developing countries, where rising incomes and standards of living have sparked a new health consciousness and growing demands for quality medical care.
The Middle East is an underserved region with large market potential. IVD in the Middle East provides data on the developments in the IVD industry in the Middle East, including:
- Egypt In Vitro Diagnostic Sales by Market Segment to 2021
- Egypt - POC Market Distribution to 2021
- Turkey In Vitro Diagnostic Sales by Market Segment to 2021
- Turkey - POC Market Distribution to 2021
- Saudi Arabia In Vitro Diagnostic Sales by Market Segment to 2021
- Saudi Arabia - POC Market Distribution to 2021
- Israel In Vitro Diagnostic Sales by Market Segment to 2021
- Israel - POC Market Distribution to 2021
- United Arab Emirates In Vitro Diagnostic Sales by Market Segment to 2021
- United Arab Emirates - POC Market Distribution to 2021
- Jordan In Vitro Diagnostic Sales by Market Segment to 2021
- Jordan - POC Market Distribution, 2016-2021
- Mideast In Vitro Diagnostic Sales by Market Segment to 2021
- Mideast In Vitro Diagnostic Sales by Country, 2016-2021 (Egypt, Turkey, Saudi Arabia, United Arab Emirates, Israel, Jordan, Other Mideast, Total)
Key Topics Covered:
1: Executive Summary
Overview
Scope and Methodology
Size and Growth of the Market
2: Middle East: Regional Overview
Population
Economic Outlook
Major Diseases Affecting the Middle Eastern Population
Diabetes
Cardiovascular Diseases
Cancer
Middle Eastern Respiratory Syndrome (MERS)
Arab Health Congress
3: Market Analysis
Overview
Egypt IVD Market
Market Drivers
Market Inhibitors
Market Participant Activity
Turkey IVD Market
Market Drivers
Market Inhibitors
Market Participant Activity
Saudi Arabia IVD Market
Market Drivers
Market Inhibitors
Market Participant Activity
Israel IVD Market
Market Drivers
Market Inhibitors
Market Participant Activity
United Arab Emirates (UAE) IVD Market
Market Drivers
Market Participant Activity
Jordan IVD Market
Market Drivers
Market Participant Activity
Total Mideast Market
Clinical Chemistry Market
Microbiology Market
Point-of-Care Market
Histology Market
Other Markets - Immunoassays
For more information about this report visit http://www.researchandmarkets.com/research/mqk3h4/ivd_in_the_middle
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Healthcare Services, Africa, In Vitro Diagnostics, Point-of-Care Diagnostics


Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change 



